What is RootPath?
RootPath is a synthetic biology firm dedicated to significantly enhancing the throughput of gene function interrogation. Leveraging molecular programming-based DNA fragment assembly technology, the company provides researchers and drug developers with unparalleled access to accurate, long synthetic genes and their functional readouts. RootPath's mission is to enable biology at scale, addressing critical needs within the research and drug development sectors.
How much funding has RootPath raised?
RootPath has raised a total of $11M across 1 funding round:
Other Financing Round
$11M
Other Financing Round (2020): $11M, investors not publicly disclosed
What's next for RootPath?
With this major enterprise-level funding and strategic investment, RootPath is poised for accelerated growth and innovation. The capital infusion is expected to fuel further development of their proprietary DNA assembly technology, expand their research and development capabilities, and strengthen their market position in the synthetic biology and drug discovery landscapes. This financing round signals strong confidence in RootPath's ability to scale its operations and impact the future of biological research.
See full RootPath company page
